Jasper Therapeutics, Inc. (JSPR)
NASDAQ·Healthcare·Biotechnology
$0.92
-0.84%
Mkt Cap $21.29M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | — | — | -$0.79 | -$0.32 | +59.49% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$1.01 | -$1.13 | -11.88% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$1.20 | -$1.74 | -45.00% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$1.17 | -$1.41 | -20.51% | — | — |
| Q1 2025 Feb 27, 2025 | — | $1.17M | — | -$1.27 | -$1.62 | -27.56% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$1.09 | -$1.24 | -13.76% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$1.09 | -$0.97 | +11.01% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$1.26 | -$1.03 | +18.25% | — | — |
| Q1 2024 Mar 4, 2024 | — | $2.05M | — | -$1.65 | -$1.50 | +9.09% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$1.50 | -$1.60 | -6.67% | — | — |
| Q3 2023 Aug 11, 2023 | — | — | — | -$1.30 | -$1.50 | -15.38% | — | — |
| Q2 2023 May 12, 2023 | — | — | — | -$1.50 | -$1.60 | -6.67% | — | — |
| Q1 2023 Mar 8, 2023 | — | — | — | -$3.70 | -$3.60 | +2.70% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$3.50 | -$3.20 | +8.57% | — | — |
| Q3 2022 Aug 12, 2022 | — | — | — | -$2.90 | -$2.90 | +0.00% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$3.60 | -$3.50 | +2.78% | — | — |
| Q1 2022 Mar 18, 2022 | — | — | — | -$0.34 | -$0.79 | -132.35% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | -$0.28 | -$0.69 | -146.43% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | — | -$0.84 | — | — | — |
| Q2 2021 May 24, 2021 | — | — | — | — | -$0.26 | — | — | — |